These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23617326)

  • 1. Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome.
    Sogabe M; Okahisa T; Tsujigami K; Fukuno H; Hibino S; Yamanoi A
    Hepatol Res; 2014 May; 44(5):515-22. PubMed ID: 23617326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.
    Sogabe M; Okahisa T; Hibino S; Yamanoi A
    J Gastroenterol; 2012 Mar; 47(3):293-9. PubMed ID: 22065161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
    Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T
    BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome.
    Sogabe M; Okahisa T; Taniguchi T; Tomonari T; Tanaka T; Tanaka H; Nakasono M; Takayama T
    Liver Int; 2015 Jun; 35(6):1707-14. PubMed ID: 25438866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    Sogabe M; Okahisa T; Nakasono M; Fukuno H; Miyamoto Y; Okada Y; Okazaki J; Miyoshi J; Tomonari T; Taniguchi T; Goji T; Kitamura S; Miyamoto H; Muguruma N; Takayama T
    PLoS One; 2017; 12(6):e0177925. PubMed ID: 28574988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral fat predominance is associated with erosive esophagitis in Japanese men with metabolic syndrome.
    Sogabe M; Okahisa T; Kimura Y; Hibino S; Yamanoi A
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):910-6. PubMed ID: 22617364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.
    Ishibashi E; Eguchi Y; Eguchi T; Matsunobu A; Oza N; Nakashita S; Kitajima Y; Kuroki S; Ozaki I; Kawaguchi Y; Ide Y; Yasutake T; Iwakiri R; Mizuta T; Ono N; Fujimoto K
    J Gastroenterol Hepatol; 2008 Jun; 23(6):908-13. PubMed ID: 18373563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects.
    Preuss HG; Kaats GR; Mrvichin N; Swaroop A; Bagchi D; Clouatre D; Preuss JM
    J Am Coll Nutr; 2018 Aug; 37(6):457-465. PubMed ID: 29652564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
    Sanyal D; Mukherjee P; Raychaudhuri M; Ghosh S; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2015; 19(5):597-601. PubMed ID: 26425466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between low thigh fat and non-alcoholic fatty liver disease.
    Jun DW; Han JH; Kim SH; Jang EC; Kim NI; Lee JS; Song MH; Kim SH; Jo YJ; Park YS
    J Gastroenterol Hepatol; 2008 Jun; 23(6):888-93. PubMed ID: 18466289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.
    Omagari K; Kadokawa Y; Masuda J; Egawa I; Sawa T; Hazama H; Ohba K; Isomoto H; Mizuta Y; Hayashida K; Murase K; Kadota T; Murata I; Kohno S
    J Gastroenterol Hepatol; 2002 Oct; 17(10):1098-105. PubMed ID: 12201871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.
    de Jonge C; Rensen SS; Koek GH; Joosten MF; Buurman WA; Bouvy ND; Greve JW
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1517-20. PubMed ID: 23920034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
    Chien-Min K; Cheng-Chuan L
    Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
    Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
    Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.